Due to its histone methyltransferase activity, EZH2 can specifically trimethylate the histone H3 lysine 27 (H3K27me3) to inhibit the expression of downstream tumor-suppressive genes at the transcriptional level, which promote the proliferation and decrease the apoptosis of cancer cells [1–3]. This evidence concerns the gene EZH2 and neoplasm.